Zangerl-Plessl Eva-Maria, Wu Wei, Sanguinetti Michael C, Stary-Weinzinger Anna
1 Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.
Department of Internal Medicine, Nora Eccles Harrison Cardiovascular Research & Training Institute, Division of Cardiovascular Medicine, University of Utah, Salt Lake City, UT, United States.
Front Mol Biosci. 2023 Feb 23;10:1137368. doi: 10.3389/fmolb.2023.1137368. eCollection 2023.
The opening and closing of voltage-dependent potassium channels is dependent on a tight coupling between movement of the voltage sensing S4 segments and the activation gate. A specific interaction between intracellular amino- and carboxyl-termini is required for the characteristically slow rate of channel closure (deactivation) of hERG1 channels. Compounds that increase hERG1 channel currents represent a novel approach for prevention of arrhythmia associated with prolonged ventricular repolarization. RPR260243 (RPR), a quinoline oxo-propyl piperidine derivative, inhibits inactivation and dramatically slows the rate of hERG1 channel deactivation. Here we report that similar to its effect on wild-type channels, RPR greatly slows the deactivation rate of hERG1 channels missing their amino-termini, or of split channels lacking a covalent link between the voltage sensor domain and the pore domain. By contrast, RPR did not slow deactivation of C-terminal truncated hERG1 channels or D540K hERG1 mutant channels activated by hyperpolarization. Together, these findings indicate that ability of RPR to slow deactivation requires an intact C-terminus, does not slow deactivation by stabilizing an interaction involving the amino-terminus or require a covalent link between the voltage sensor and pore domains. All-atom molecular dynamics simulations using the cryo-EM structure of the hERG1 channel revealed that RPR binds to a pocket located at the intracellular ends of helices S5 and S6 of a single subunit. The slowing of channel deactivation by RPR may be mediated by disruption of normal S5-S6 interactions.
电压依赖性钾通道的开放和关闭取决于电压感应S4片段的移动与激活门之间的紧密耦合。hERG1通道特征性的缓慢关闭速率(失活)需要细胞内氨基末端和羧基末端之间的特定相互作用。增加hERG1通道电流的化合物代表了一种预防与心室复极延长相关的心律失常的新方法。喹啉氧代丙基哌啶衍生物RPR260243(RPR)可抑制失活并显著减慢hERG1通道的失活速率。在此我们报告,与它对野生型通道的作用类似,RPR极大地减慢了缺失氨基末端的hERG1通道或电压传感器结构域与孔道结构域之间缺乏共价连接的分裂通道的失活速率。相比之下,RPR并没有减慢C末端截短的hERG1通道或超极化激活的D540K hERG1突变通道的失活。这些发现共同表明,RPR减慢失活的能力需要完整的C末端,不是通过稳定涉及氨基末端的相互作用来减慢失活,也不需要电压传感器和孔道结构域之间的共价连接。使用hERG1通道的冷冻电镜结构进行的全原子分子动力学模拟表明,RPR结合到单个亚基的螺旋S5和S6细胞内末端的一个口袋中。RPR对通道失活的减慢可能是由正常的S5 - S6相互作用的破坏介导的。